You are viewing: Rest Of Middle East Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Rest Of Middle East Long Read Sequencing Market was valued at $8.1 Million in 2024 and projected to reach to $26.7 Million by 2029, representing a compound annual growth rate of 26.8%. The Rest Of Middle East long read sequencing market is positioned for substantial growth through 2029, driven by expanding healthcare investments and rising adoption of advanced genomic technologies.

Rest Of Middle East Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Middle East Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 26.8%, reflecting increasing adoption of advanced genomic sequencing technologies across the region.
  • Rest Of Middle East is witnessing growing investment in healthcare infrastructure and genomic research capabilities, driving demand for long read sequencing platforms that enable comprehensive DNA analysis. Rest Of Middle East's market growth is fueled by rising prevalence of genetic disorders, expanding pharmaceutical and biotechnology sectors, and government initiatives supporting precision medicine.
  • The region's healthcare institutions are increasingly recognizing the clinical and research value of long read sequencing for complex genomic applications.
  • Rest Of Middle East is positioning itself as an emerging hub for genomic innovation, with healthcare providers and research organizations adopting these technologies to improve diagnostic accuracy and accelerate drug discovery programs through 2029..

Key Market Statistics

  • CAGR (2024-2029) 26.8% CAGR
  • Market Size, 2024 ~USD 8.1 Million
  • Forecast, 2029 ~USD 26.7 Million
  • Country Rest Of Middle East

Rest Of Middle East Long Read Sequencing Market Overview

Rapid Market Expansion :

Rest Of Middle East long read sequencing market is growing at 26.8% CAGR, expanding from $8.1 million in 2024 to $26.7 million by 2029, demonstrating strong regional adoption of advanced genomic technologies.

Healthcare Infrastructure Investment :

The region is witnessing substantial investment in healthcare infrastructure and genomic research facilities, creating favorable conditions for long read sequencing technology deployment across diagnostic and research centers.

Outpacing Global Growth :

While the global long read sequencing market grows at 32.8% CAGR, Rest Of Middle East's 26.8% growth rate reflects localized adoption patterns and emerging market dynamics specific to the region's healthcare ecosystem.

Emerging Genomic Adoption :

Increasing awareness of precision medicine and genetic testing among healthcare providers and patients in Rest Of Middle East is driving demand for long read sequencing applications in clinical diagnostics and research.

Rest Of Middle East Long Read Sequencing Market Dynamics

  • Regional governments and private healthcare institutions are increasingly recognizing the clinical value of long read sequencing for rare disease diagnosis, cancer genomics, and personalized medicine applications.
  • This growing recognition is catalyzing infrastructure development and talent acquisition across the region. Key growth drivers include improving healthcare accessibility, rising prevalence of genetic disorders, and increasing collaboration with international genomic research institutions.
  • As healthcare budgets expand and awareness of precision medicine grows, Rest Of Middle East is expected to emerge as a significant market for long read sequencing platforms and services, attracting both regional and international market players seeking to establish presence in this high-growth emerging market..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Rest Of Middle East long read sequencing market valued at $8.1 million in 2024, expanding to $26.7 million by 2029 at 26.8% CAGR
    • Rest Of Middle East is experiencing increased healthcare infrastructure investment and genomic research capability development driving market adoption
    • Rest Of Middle East's growing pharmaceutical and biotechnology sectors are accelerating demand for advanced sequencing technologies in drug discovery
    • Rest Of Middle East healthcare institutions are prioritizing precision medicine initiatives, positioning the region as an emerging genomic innovation hub

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Rest Of Middle East Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Healthcare Providers & Hospital Networks : Rest Of Middle East hospital systems and diagnostic centers need market intelligence to evaluate long read sequencing adoption, assess technology ROI, and plan genomic medicine service expansion.
    • Sequencing Technology Vendors : Equipment manufacturers and platform providers require Rest Of Middle East-specific market data to identify growth opportunities, assess regional demand, and develop localized commercialization strategies.
    • Healthcare Investors & Private Equity : Investment firms targeting Rest Of Middle East healthcare sector need detailed market forecasts and growth drivers to evaluate investment opportunities in genomic sequencing companies and infrastructure.
    • Government & Healthcare Policy Makers : Regional health ministries and policy bodies require market insights to inform healthcare technology adoption policies, budget allocation, and precision medicine infrastructure development initiatives.
    • Research Institutions & Academic Centers : Universities and research organizations in Rest Of Middle East need market data to justify genomic sequencing investments, secure funding, and align research capabilities with regional healthcare needs.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Middle East ($8.1M in 2024, $26.7M by 2029) with detailed CAGR analysis to support investment decisions and market entry strategies in this high-growth region.
    • Competitive Landscape Intelligence : Understand regional market dynamics, key players, and competitive positioning specific to Rest Of Middle East's long read sequencing sector to identify partnership and expansion opportunities.
    • Growth Driver Analysis : Identify region-specific factors driving 26.8% CAGR growth, including healthcare infrastructure investments, regulatory developments, and adoption patterns unique to Rest Of Middle East markets.
    • Strategic Market Entry Planning : Leverage Rest Of Middle East-focused insights to develop targeted go-to-market strategies, assess market readiness, and prioritize resource allocation for regional expansion initiatives.
    • Investment & Funding Opportunities : Discover emerging investment opportunities and funding landscape in Rest Of Middle East's genomic sequencing sector to identify venture capital, government grants, and partnership prospects.

    Frequently asked questions

    What is the current market size of long read sequencing in Rest Of Middle East?

    Rest Of Middle East's long read sequencing market was valued at $8.1 million in 2024 and is projected to grow to $26.7 million by 2029.

    What is the growth rate for long read sequencing in Rest Of Middle East?

    Rest Of Middle East's long read sequencing market is growing at a compound annual growth rate of 26.8% from 2024 to 2029.

    What factors are driving long read sequencing adoption in Rest Of Middle East?

    Rest Of Middle East's market growth is driven by increased healthcare infrastructure investment, rising genetic disorder prevalence, expanding biotech sectors, and government precision medicine initiatives.

    Which applications are most prominent for long read sequencing in Rest Of Middle East?

    Rest Of Middle East is seeing significant adoption in clinical diagnostics, pharmaceutical drug discovery, genetic research, and precision medicine applications across healthcare institutions.

    How is Rest Of Middle East positioning itself in the global long read sequencing market?

    Rest Of Middle East is emerging as a regional genomic innovation hub, with healthcare providers and research organizations increasingly adopting long read sequencing to improve diagnostic accuracy and accelerate research programs.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status